Trade Harmony Biosciences Holdings, Inc. - HRMY CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.14 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 34.83 |
| Open | 34.95 |
| 1-Year Change | 6.2% |
| Day's Range | 33.94 - 34.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 34.48 | -0.47 | -1.34% | 34.95 | 35.10 | 33.86 |
| Feb 20, 2025 | 34.83 | -0.23 | -0.66% | 35.06 | 35.12 | 34.22 |
| Feb 19, 2025 | 35.26 | -1.44 | -3.92% | 36.70 | 36.90 | 34.94 |
| Feb 18, 2025 | 38.94 | -0.04 | -0.10% | 38.98 | 39.24 | 38.11 |
| Feb 14, 2025 | 38.93 | -0.02 | -0.05% | 38.95 | 39.72 | 38.51 |
| Feb 13, 2025 | 39.01 | 0.57 | 1.48% | 38.44 | 39.79 | 37.90 |
| Feb 12, 2025 | 37.78 | 0.55 | 1.48% | 37.23 | 38.63 | 37.18 |
| Feb 11, 2025 | 37.68 | -0.63 | -1.64% | 38.31 | 38.35 | 37.00 |
| Feb 10, 2025 | 37.89 | 0.39 | 1.04% | 37.50 | 38.05 | 37.28 |
| Feb 7, 2025 | 37.33 | -1.28 | -3.32% | 38.61 | 38.71 | 37.20 |
| Feb 6, 2025 | 38.71 | -0.20 | -0.51% | 38.91 | 39.45 | 38.58 |
| Feb 5, 2025 | 39.31 | 0.14 | 0.36% | 39.17 | 39.90 | 38.55 |
| Feb 4, 2025 | 38.91 | 0.26 | 0.67% | 38.65 | 38.99 | 37.98 |
| Feb 3, 2025 | 38.66 | 0.75 | 1.98% | 37.91 | 39.01 | 37.46 |
| Jan 31, 2025 | 38.68 | -0.88 | -2.22% | 39.56 | 39.56 | 38.37 |
| Jan 30, 2025 | 39.49 | 0.54 | 1.39% | 38.95 | 39.86 | 38.59 |
| Jan 29, 2025 | 38.77 | 0.40 | 1.04% | 38.37 | 39.08 | 37.80 |
| Jan 28, 2025 | 38.32 | 0.12 | 0.31% | 38.20 | 39.14 | 37.87 |
| Jan 27, 2025 | 38.18 | 0.23 | 0.61% | 37.95 | 38.72 | 37.58 |
| Jan 24, 2025 | 37.93 | 0.07 | 0.18% | 37.86 | 37.94 | 36.41 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Harmony Biosciences Holdings, Inc. Company profile
About Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings, Inc. is a holding company. The Company through its subsidiary, Harmony Biosciences, LLC., operates as a pharmaceutical company, which is focused on therapies for patients suffering from central nervous system disorders. It provides treatment options for people living with rare and orphan diseases, with an emphasis on central nervous system disorders, patients living with narcolepsy. It enables to know narcolepsy and provides information and resources to individuals who live with, and healthcare professionals who treat patients with, this disorder. The Company’s product, WAKIX (pitolisant), is a molecule with mechanism of action (MOA), designed to histamine signaling in the brain by binding to H3 receptors. It also provides HBS-102, a Melanin Concentrating Hormone Receptor One (MCHR1) antagonist that offers treatment of narcolepsy, including the symptoms of Rapid Eye Movement (REM) sleep dysregulation, such as cataplexy, hallucinations and sleep paralysis.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Harmony Biosciences Holdings Inc revenues increased 91% to $305.4M. Net income applicable to common stockholders totaled $34.6M vs. loss of $63.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Interest expense, net decrease of 15% to $24M (expense), Other income (expense).
| Industry: | Pharmaceuticals (NEC) |
630 W Germantown Pike
Suite 215
PLYMOUTH MEETING
PENNSYLVANIA 19462
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com